Cullen/Frost Bankers, Inc. Staar Surgical CO Transaction History

Cullen/Frost Bankers, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$50.24 - $80.48 $251 - $402	5 Added 0.13%	3,835 $272,000
Q1 2022 May 09, 2022	SELL	$57.98 - $93.5 $213,656 - $344,547	-3,685 Reduced 49.04%	3,830 $306,000
Q4 2021 Feb 07, 2022	SELL	$88.02 - $127.79 $27,726 - $40,253	-315 Reduced 4.02%	7,515 $686,000
Q3 2021 Nov 04, 2021	SELL	$122.75 - $162.68 $27,005 - $35,789	-220 Reduced 2.73%	7,830 $1.01 Million
Q2 2021 Aug 05, 2021	BUY	$105.76 - $154.96 $33,314 - $48,812	315 Added 4.07%	8,050 $1.23 Million
Q3 2020 Nov 05, 2020	BUY	$45.65 - $61.81 $27,390 - $37,086	600 Added 8.41%	7,735 $437,000
Q2 2020 Aug 05, 2020	BUY	$29.15 - $61.54 $207,985 - $439,087	7,135 New	7,135 $439,000

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.35B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.